Let's examine how these compounds behave in the body, focusing on their absorption and distribution characteristics
B12 testing is recommended in patients with fatty liver disease who have: Symptoms suggestive of deficiency (anaemia, neuropathy, cognitive changes) Long-term metformin use (MHRA 2022 guidance advises monitoring) Long-term proton pump inhibitor use Vegetarian or vegan diets Conditions affecting absorption (pernicious anaemia, coeliac disease, gastric surgery) Advanced liver disease (NASH, fibrosis, or cirrhosis) Monitoring frequency should be individualised based on disease severity and risk factors
Supply unlicensed medicinal products (specials) GOV.UK
This can help improve overall health and wellness, and reduce the risk of chronic diseases
This evidence-based approach avoids unnecessary supplementation costs and simplifies the protocol for people who do not need additional b12
Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure